Strs Ohio Has $6.40 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Strs Ohio increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 10.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,288 shares of the company’s stock after buying an additional 8,100 shares during the quarter. Strs Ohio’s holdings in Acadia Healthcare were worth $6,398,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Fifth Third Bancorp raised its position in Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the last quarter. Estate Counselors LLC raised its position in Acadia Healthcare by 0.9% in the 3rd quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock valued at $1,154,000 after purchasing an additional 145 shares during the last quarter. Verition Fund Management LLC raised its position in Acadia Healthcare by 4.5% in the 4th quarter. Verition Fund Management LLC now owns 3,601 shares of the company’s stock valued at $296,000 after purchasing an additional 155 shares during the last quarter. Truist Financial Corp raised its position in Acadia Healthcare by 0.3% in the 4th quarter. Truist Financial Corp now owns 49,387 shares of the company’s stock valued at $4,066,000 after purchasing an additional 171 shares during the last quarter. Finally, Mackenzie Financial Corp raised its position in Acadia Healthcare by 1.3% in the 3rd quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock valued at $1,063,000 after purchasing an additional 199 shares during the last quarter.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.80% of the stock is owned by corporate insiders.

Acadia Healthcare Stock Up 0.0 %

NASDAQ:ACHC opened at $70.28 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The company has a market cap of $6.50 billion, a PE ratio of -281.11, a PEG ratio of 2.10 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 52-week low of $66.49 and a 52-week high of $87.77. The stock has a 50-day simple moving average of $79.42 and a 200 day simple moving average of $77.55.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. Acadia Healthcare’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the company earned $0.70 earnings per share. On average, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. TD Cowen lifted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Royal Bank of Canada restated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Monday, March 4th. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a research report on Friday, January 5th. Finally, UBS Group boosted their target price on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and an average target price of $91.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.